/assets/production/practices/3280152d22c7599df4208c7f13bd6f106ba2a939/images/2788239.jpeg)
Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
In a 2025 observational cohort, the Risk of Vestibular Disorders with Semaglutide and Tirzepatide study reported dizziness in 18% of semaglutide users compared with 10% in the control group, indicating a higher-than-baseline incidence and reinforcing the need to monitor for dose- or timing-related patterns
Not catastrophic on its own, but if youre already close to your personal tolerance ceiling, that gap matters
This can be remedied by drinking more water, eating food with fiber, and exercising regularly
Mitophagy stimulation as a novel strategy for the treatment of mitochondrial diseases
US$ 28.04
US$ 29.82
US$ 28.90
US$ 20.60
US$ 27.74
